GSR has introduced $100 million personal funding and a brand new strategic partnership in MEI Pharma (NASDAQ: MEIP). As a part of the settlement, GSR will function a strategic advisor and can handle MEI’s Ministry of Digital Belongings Treasury. The transfer factors to a brand new route for MEIs that plans to undertake Litecoin (LTC) as their core monetary belongings.
Litecoin creator Charlie Lee and GSR representatives will probably be becoming a member of Mei’s board of administrators. The Litecoin Basis helps the initiative. This growth follows earlier critiques on strategic alternate options for MEI, indicating the shift in the direction of a digital asset-focused enterprise mannequin.
GSR helps MEI handle Litecoin Holdings and help the corporate’s operations inside the digital asset house. The partnership is designed to attach the open market with crypto methods, and MEI’s management is working to regulate the objectives and new instructions of each the GSR and Litecoin Basis.
This funding additionally consists of participation from a number of crypto-centric funding firms and infrastructure suppliers. Supporting different blockchain initiatives, together with these from Polygon Community, GSR continues to offer liquidity and advisory providers all through the digital asset trade.
Picture: Freepik
